Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases.

DM control: glycosylated Hgb Hyperglycemia: complications Outpatient surgery contraindications Perioperative insulin: effects Perioperative risk of MI Postoperative cardiac event: risk factors

Journal

Journal of clinical anesthesia
ISSN: 1873-4529
Titre abrégé: J Clin Anesth
Pays: United States
ID NLM: 8812166

Informations de publication

Date de publication:
11 2021
Historique:
received: 11 02 2021
revised: 07 05 2021
accepted: 11 05 2021
pubmed: 20 6 2021
medline: 24 12 2021
entrez: 19 6 2021
Statut: ppublish

Résumé

Assess for a relationship between immediate preoperative glucose concentrations and postoperative complications. Retrospective cohort study. Single large, tertiary care academic medical center. A five-year registry of all patients at our hospital who had a glucose concentration (plasma, serum, or venous/capillary/arterial whole blood) measured up to 6 h prior to a non-emergent surgery. The glucose registry was cross-referenced with a database from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). We applied an outcomes review to the subset of patients for whom we had data from both registries (n = 1774). Preoperative glucose concentration in the full population as well as the subgroups of patients with or without diabetes were correlated with adverse postsurgical outcomes using 1) univariable analysis and 2) full multivariable analysis correcting for 27 clinical factors available from the ACS NSQIP database. Logistic regression analysis was performed using glucose level either as a continuous variable or as a categorical variable according to the following classifications: mild (≥140 mg/dL; ≥7.8 mmol/L), moderate (≥180 mg/dL; ≥10 mmol/L), or severe (≥250 mg/dL; ≥13.9 mmol/L) hyperglycemia. A third analysis was performed correcting for 7 clinically important factors (age, BMI, predicted duration of procedure, sex, CKD stage, hypoalbuminemia, and diabetic status) identified by anesthesiologists and surgeons as immediately available and important for decision making. Univariable analysis of all patients and the subgroups of patients without diabetes or with diabetes showed that immediate preoperative mild or moderate hyperglycemia correlates with postoperative complications. Statistical significance was lost in most groups using full multivariable analysis, but not when correcting for the 7 factors available immediately preoperatively. However, for all patients with diabetes, moderate hyperglycemia (≥180 mg/dL; ≥10 mmol/L) continued to significantly correlate with complications even in the full multivariable analysis [odds ratio (OR) 1.79; 95% Confidence Intervals (CI) 1.10, 2.92], and with readmission/reoperation within 30 days [OR 1.93; 95% CI 1.18, 3.13]. Preoperative hyperglycemia within 6 h of surgery is a marker of adverse postoperative outcomes. Among patients with diabetes in our study, a preoperative glucose level ≥ 180 mg/dL (≥10 mmol/L) independently correlates with risk of postoperative complications and readmission/reoperation. These results should encourage future work to determine whether addressing immediate preoperative hyperglycemia can improve complication rates, or simply serves as a marker of higher risk.

Identifiants

pubmed: 34147016
pii: S0952-8180(21)00214-2
doi: 10.1016/j.jclinane.2021.110375
pmc: PMC8627687
mid: NIHMS1757059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110375

Subventions

Organisme : BLRD VA
ID : I01 BX004468
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK054759
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Br J Anaesth. 2014 Jan;112(1):79-88
pubmed: 24009267
Am Surg. 2017 Oct 1;83(10):1108-1111
pubmed: 29391105
J Surg Res. 2014 Jan;186(1):371-8
pubmed: 24148355
N Engl J Med. 2001 Nov 8;345(19):1359-67
pubmed: 11794168
Diabetes Care. 2010 Aug;33(8):1783-8
pubmed: 20435798
Diabet Med. 2012 Apr;29(4):420-33
pubmed: 22288687
Crit Care Med. 2018 Jun;46(6):935-942
pubmed: 29509570
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
Ann Thorac Surg. 2009 Feb;87(2):663-9
pubmed: 19161815
Anesth Analg. 2010 Dec;111(6):1378-87
pubmed: 20889933
Diabetes Care. 2021 Jan;44(Suppl 1):S211-S220
pubmed: 33298426
Crit Care Med. 2012 Dec;40(12):3251-76
pubmed: 23164767
Eur J Endocrinol. 2007 Jan;156(1):137-42
pubmed: 17218737
Diabetes Care. 2015 Sep;38(9):1665-72
pubmed: 26180108
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
J Thorac Cardiovasc Surg. 2003 May;125(5):1007-21
pubmed: 12771873
Ann Surg. 2018 May;267(5):858-862
pubmed: 28549013
Intensive Care Med. 2016 Sep;42(9):1475-7
pubmed: 27161084
Ann Intern Med. 2007 Feb 20;146(4):233-43
pubmed: 17310047
JAMA. 2019 Jan 29;321(4):399-400
pubmed: 30615031
Diabetes Care. 2018 Apr;41(4):782-788
pubmed: 29440113
Int J Colorectal Dis. 2017 Feb;32(2):209-214
pubmed: 27864588
J Arthroplasty. 2010 Jan;25(1):64-70
pubmed: 19056217
BMC Endocr Disord. 2018 Jun 22;18(1):42
pubmed: 29929558
Ann Surg. 2013 Jan;257(1):8-14
pubmed: 23235393
JAMA Surg. 2017 Aug 1;152(8):784-791
pubmed: 28467526
Curr Diab Rep. 2019 Nov 20;19(11):134
pubmed: 31749027

Auteurs

Sarah M Dougherty (SM)

Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Julie Schommer (J)

Divison of Endocrinology, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Jorge L Salinas (JL)

Division of Infectious Disease, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Barbara Zilles (B)

Program of Hospital Epidemiology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.

Mary Belding-Schmitt (M)

Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

W Kirke Rogers (WK)

Department of Anesthesiology, University of Minnesota, Minneapolis, MN 55455, USA.

Amal Shibli-Rahhal (A)

Divison of Endocrinology, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Brian T O'Neill (BT)

Divison of Endocrinology, Department of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, University of Iowa, Iowa City, IA 52242, USA; Veterans Affairs Health Care System, Iowa City, IA 52242, USA. Electronic address: brian-oneill@uiowa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH